The biggest difference was observed for B lymphocytes, where the expression levels in the tumor samples were over five times higher (5.41 times), over two times higher for CD8+ T cells (2.34 times), and almost two times higher for CD4+ T cells (1.79 times) (Table 3). This evidence concerns the gene CD4 and neoplasm.